![](/img/cover-not-exists.png)
P340 Comorbidity is associated with safety outcomes in vedolizumab- and ustekinumab-treated inflammatory bowel disease patients
Asscher, V, Biemans, V, Pierik, M, Dijkstra, G, Van der Meulen-de Jong, A, Löwenberg, M, van der Marel, S, de Boer, N, Bodelier, A, Jansen, J, West, R, Haans, J, van Dop, W, Weersma, R, Hoentjen, F,Volume:
14
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjz203.469
Date:
January, 2020
File:
PDF, 664 KB
2020